TABLE 2.
Behavioral symptoms (ARBS ≥ 1) | Depression symptoms (PHQ‐9 ≥ 10) | |||
---|---|---|---|---|
Est. | 95% CI | Est. | 95% CI | |
Period 1 (Jan 2018–Feb 2020): Pre‐COVID‐19 | ||||
% Symptoms at beginning of period 1 (Jan 2018) | 20.0 | 2.9 | ||
Slope during pre‐COVID‐19 period | 0.002 | −0.04, 0.04 | 0.01 | −0.01, 0.03 |
Period 2 (Mar 2020 – Jun 2021): During COVID‐19 | ||||
Slope during COVID‐19 period | 0.05 | −0.02, 0.12 | 0.04 | 0.02, 0.06* |
Slope change pre‐ and during COVID‐19 | 0.05 | −0.04, 0.14 | 0.03 | 0.004, 0.06* |
% Symptoms at end of period 2 (Jun 2021) | 19.9 | 4.0 |
Abbreviations: Est., estimate; 95% CI, 95% confidence interval; ARBS, Agitated Reactive Behavior Scale; PHQ‐9, Patient Health Questionnaire‐9.
Note: Residents with diagnoses of Huntington's disease, Tourette syndrome, or schizophrenia were excluded. Prevalence reported in the predicted percent from the interrupted time series model.
p < .05.